What Are The Strategic Insights Behind The Bleeding Disorder Testing Market Expansion To $21.87 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Bleeding Disorder Testing Market?
Over the past few years, the market size for bleeding disorder testing has seen considerable growth. The market is anticipated to increase from $14.99 billion in 2024 to $16.18 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. Several factors can explain the growth observed in the historic period, including a higher frequency of bleeding disorders, increased funding for research and development, the surge in specialized clinics, an amplified demand for early diagnosis, and an upturn in clinical trials.
The market for bleeding disorder testing is predicted to experience substantial growth in the upcoming years, reaching a market size of $21.87 billion in 2029, with a compound annual growth rate (CAGR) of 7.8%. This expected growth over the forecast period can be linked to factors such as an increased occurrence of hemophilia, greater recognition of bleeding disorder symptoms, an escalation in diagnostic research investment, an increase in global healthcare expenditure, and a surge in cases of rare bleeding disorders. The forthcoming period is likely to observe major trends such as technological progress, the incorporation of artificial intelligence, personalized healthcare approaches, telemedicine facilities, and home-based testing kits.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18263&type=smp
What Core Drivers Are Expected To Influence The Bleeding Disorder Testing Market?
The surge in the number of clinical trials is anticipated to boost the expansion of the bleeding disorder testing market. Clinical trials represent research studies that evaluate the safety and effectiveness of new medical procedures, treatments, drugs, or technology on humans. The escalation in clinical trials can be attributed to progress in medical research, increased investment in healthcare innovation, and a heightened demand for new treatment methods and therapies. Bleeding disorder tests are utilized in clinical trials to determine the safety and effectiveness of new treatments and medications for bleeding disorders, gauge how well these treatments address clotting irregularities, and oversee patient reactions to ensure maximum dosage and efficiency. For example, as per ClinicalTrials.gov, a clinical trial registry based in the US, about 477,228 clinical trials were registered at the end of 2023, marking an increase from 437,507 in 2022. Therefore, the ascending number of clinical trials is fuelling the growth of the bleeding disorder testing market.
Which Segmentation Categories Are Highlighted In The Bleeding Disorder Testing Market Analysis?
The bleeding disorder testingmarket covered in this report is segmented –
1) By Product Type: Reagents And Consumables; Instruments
2) By Indication: Hemophilia A; Hemophilia B; Von Willebrand Disease; Idiopathic Thrombocytopenic Purpura; Other Indications
3) By Treatment Type: Factor Replacement Therapy; Drug Therapy
4) By End User: Hospitals And Clinics; Diagnostic Centers; Other End Users
Subsegments:
1) By Reagents And Consumables: Coagulation Reagents; Plasma And Blood Collection Consumables; Hemostasis Reagents; Factor Deficiency Assay Kits; Activated Partial Thromboplastin Time (APTT) Reagents
2) By Instruments: Coagulation Analyzers; Platelet Function Analyzers; Hemostasis Testing Instruments; Point-Of-Care Testing Devices; Automated Blood Testing Systems
Which Notable Trends Are Transforming The Bleeding Disorder Testing Market Outlook?
Firms operating prominently in the bleeding disorder testing market are honing their strategies on the introduction of novel products, including Hemophilia B gene therapy. This innovative product aims to deliver enduring solutions, cure inherited bleeding irregularities, improve therapy results, and widen their market penetration. Hemophilia B is defined by a shortage in clotting factor IX, necessary for correct blood coagulation. The development of gene therapy for Hemophilia B is a modern treatment intending to offer a long-lasting answer by resolving the genetic fault behind the condition. In February 2023, the European Commission and CSL Limited, a biotechnology enterprise based in Australia, validated a conditional marketing authorization (CMA) for HEMGENIX. This is the first and only single-use gene therapy approved for severe and moderate hemophilia B treatment. This unique therapy targets enduring potency, diminishing or eradicating the requirement for regular factor replacement treatment. HEMGENIX is recognized for its pioneering method to gene therapy, providing a groundbreaking alternative for people living with hemophilia B, possibly redefining the care standards in the sector.
Who Are The Dominant Players In The Bleeding Disorder Testing Market Today?
Major companies operating in the bleeding disorder testing market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Siemens Healthcare GmbH, Baxter International Inc., CSL Limited, Octapharma AG, HORIBA Ltd., Haemonetics Corporation, Diagnostica Stago S.A.S., Sekisui Diagnostics LLC, Helena Laboratories Corporation, LFB Group, Sysmex Inostics GmbH, Medexus Pharmaceuticals Inc., Precision Biologics Inc., Corgenix Inc., Diapharma Group Inc., Hyphen BioMed, Hema Biologics LLC
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Bleeding Disorder Testing Market?
North America was the largest region in the bleeding disorder testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=18263&type=smp
Browse Through More Reports Similar to the Global Bleeding Disorder Testing Market 2025, By The Business Research Company
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Bleeding Disorders Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Cyclic Heavy Menstrual Bleeding Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
